Archive for March, 2018

We tested the hypothesis that poor sense of smell is associated with lower cognitive function and higher mild cognitive impairment (MCI) prevalence. Read & Research Alzheimer’s More

Be the first to comment

Neuroimaging modalities can measure different aspects of the disease process in Alzheimer’s disease, although the relationship between these modalities is unclear. Read & Research Alzheimer’s More

Be the first to comment

It is a challenge to find participants for Alzheimer’s disease (AD) prevention trials within a short period of time. The European Prevention of Alzheimer’s Dementia Registry aims to facilitate recruitment by preselecting subjects from ongoing cohort studies. This article introduces this novel approach. Read & Research Alzheimer’s More

Be the first to comment

The ability of Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers (amyloid β peptide 1–42, total tau, and phosphorylated tau) to discriminate AD from related disorders is limited. Biomarkers for other concomitant pathologies (e.g., CSF α-synuclein [α-syn] for Lewy body pathology) may be needed to further improve the differential diagnosis. Read & Research Alzheimer’s More

Be the first to comment

Researchers claim that taking the common anti-inflammatory drug ibuprofen every day from the age of 55 could prevent Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment

A study shows how an antibody that targets the APOE protein halved brain levels of plaque in mice with Alzheimer’s disease without harming APOE in the blood. Read & Research Alzheimer’s More

Be the first to comment

Apolipoprotein E (APOE)-ε4 is the major genetic risk factor for Alzheimer’s disease. However, the dose-dependent impact of this allele on brain morphology of healthy individuals remains unclear. Read & Research Alzheimer’s More

Be the first to comment

Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer’s disease (AD), but its prevalence is unclear because earlier studies did not require biomarker evidence of amyloid β (Aβ) pathology. Read & Research Alzheimer’s More

Be the first to comment

Individuals in early stages of Alzheimer’s disease are a targeted population for secondary prevention trials aimed at preserving normal cognition. Understanding within-person biomarker(s) change over time is critical for trial enrollment and design. Read & Research Alzheimer’s More

Be the first to comment

Harmful formations in the brains of people with Alzheimer’s might be responsible for much of the neural damage. Can a beet-derived pigment prevent the harm? Read & Research Alzheimer’s More

Be the first to comment

Agitation and aggression are among the most challenging symptoms of dementia. Agitated persons with dementia can harm themselves, their caregivers, or other patients in a care facility. Automatic detection of agitation would be useful to alert caregivers so that appropriate interventions can be performed. The building blocks in the automatic Read & Research Alzheimer’s More

Be the first to comment

Biomedical data sets are becoming increasingly larger and a plethora of high-dimensionality data sets (“Big Data”) are now freely accessible for neurodegenerative diseases, such as Alzheimer’s disease. It is thus important that new informatic analysis platforms are developed that allow the organization and interrogation of Big Data resources into a Read & Research Alzheimer’s More

Be the first to comment

A new study from Sweden asks whether the level of physical fitness at middle age could influence women’s risk of developing dementia later in life. Read & Research Alzheimer’s More

Be the first to comment

Alzheimer’s disease is a neurodegenerative disorder that is hypothesized to involve epigenetic dysregulation of gene expression in the brain. Read & Research Alzheimer’s More

Be the first to comment

Neuropsychiatric symptoms are common in Alzheimer’s disease. Previous research has attempted to identify subsyndromes—sets of symptoms related to one another—to clarify underlying mechanisms and treatment targets. We examined the stability of these subsyndromes over time. Read & Research Alzheimer’s More

Be the first to comment

The ε4 allele of the apolipoprotein E (APOE) gene is a prominent risk factor for Alzheimer’s disease (AD), but its implication in other dementias is less well studied. Read & Research Alzheimer’s More

Be the first to comment

Inheritance of the ε4 allele of apolipoprotein E (APOE) increases a person’s risk of developing both Alzheimer’s disease (AD) and Lewy body dementia (LBD), yet the underlying mechanisms behind this risk are incompletely understood. The recent identification of reduced APOE DNA methylation in AD postmortem brains prompted this study to Read & Research Alzheimer’s More

Be the first to comment

Excessive daytime sleepiness may be an early warning sign of Alzheimer’s, but what is the possible mechanism underlying this association? Read & Research Alzheimer’s More

Be the first to comment

A new study has proposed that blood levels of branched-chain amino acids and other metabolites may reveal risk of future dementia and Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment

The TOMM40 poly-T is a polymorphism in intron 6 of the TOMM40 gene, which is adjacent to and in linkage disequilibrium with APOE. Roses et al identified the association between the length of TOMM40 poly-T with the risk and age of onset of late-onset Alzheimer’s disease (LOAD). Following the original discovery, Read & Research Alzheimer’s More

Be the first to comment

Two new studies show how a receptor activates immune cells in the brain to ‘eat up’ amyloid beta, thereby slowing down the progression of Alzheimer’s. Read & Research Alzheimer’s More

Be the first to comment

Among adults in their 50s, researchers identified those with mild cognitive impairment — a precursor of Alzheimer’s — from their polygenic risk scores. Read & Research Alzheimer’s More

Be the first to comment

Amid rising worries that sports-related head injuries may damage health long-term, a new study suggests that they may be tied to the onset of dementia. Read & Research Alzheimer’s More

Be the first to comment

Metabolite, lipid, and lipoprotein lipid profiling can provide novel insights into mechanisms underlying incident dementia and Alzheimer’s disease. Read & Research Alzheimer’s More

Be the first to comment

Having cholesterol higher than it was in midlife was linked to lower risk of marked cognitive decline in those aged 85–94, compared with those aged 75–84. Read & Research Alzheimer’s More

Be the first to comment

Some associations of high total cholesterol with dementia risk diminish as the outcome age—age at cognitive assessment—increases. Read & Research Alzheimer’s More

Be the first to comment

Levels of amyloid β peptide 42 (Aβ42), total tau, and phosphorylated tau-181 are well-established cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease, but variability in manual plate-based assays has limited their use. We examined the relationship between CSF biomarkers, as measured by a novel automated immunoassay platform, and amyloid positron emission Read & Research Alzheimer’s More

Be the first to comment